William Larkins
Corporate Officer/Principal bij HIKMA PHARMACEUTICALS PLC
Profiel
William C.
Larkins is currently the President-Injectables Business at Hikma Pharmaceuticals Plc.
Prior to his current position, he served as the Chief Executive Officer & Director at CUSTOpharm, Inc. Dr. Larkins holds a doctorate degree from The Ohio State University and an undergraduate degree from Purdue University.
Actieve functies van William Larkins
| Bedrijven | Functie | Begin |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01-01-2022 |
Eerdere bekende functies van William Larkins
| Bedrijven | Functie | Einde |
|---|---|---|
CUSTOpharm, Inc.
 CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Algemeen Directeur | 01-09-2022 |
Opleiding van William Larkins
| Purdue University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Health Technology |
